Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Global Butyric Acid Market

Global Butyric Acid Market Share

Report ID: GMI3549
Published Date: Mar 2021
Report Format: PDF

Download Free Sample

Butyric Acid Market Share

Global butyric acid industry is fragmented, and key players include:

OXEA GmbH
Beijing Huamaoyuan Fragrance Flavor Co., ltd
Perstorp Holding AB
Dmitrievsky Chemical Plant
Eastman Chemical Company
Tokyo Chemical Industry Co. Ltd
Blue Marble Biomaterials
Snowco industrial Co., Ltd
Alfa Aesar GmbH & CO KG

Moreover, other small manufacturers are also showing keen interest in the market owing to its wide array of application in many of the end use industry such as pharmaceutical, food & beverage, and chemical. In addition, manufacturers are also engaged in several activities to strengthen its position in the market.

On 26^th May 2017. Oxea GmbH has raised its carboxylic acids production facility in Germany and strengthen its market position. Through this the company has enhanced the production short-chain fatty acids such as isobutyric acid, butyric acid and propionic acid. These listed products are mostly used in the animal feed industry, as it is used as building blocks for feed materials.

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

The global butyric acid industry size was more than USD 175 million in 2020 and will witness nearly 13.2% CAGR up to 2027 with higher consumption in the pharmaceutical and food applications.

The market share of butyric acid from use in the cosmetics sector is projected to go beyond USD 17.5 million by 2027 with growing use in perfume additives and other similar products.

Global butyric acid industry share from the renewable type segment is expected to surpass USD 225 million by 2027 with consistent rise in the demand for bio-based ingredients.

It is expected that the industry share from animal feed application segment could hit USD 105 million by 2027 with the increasing need to tackle problems like infectious animal diseases and intestinal health.

North America is anticipated to reach USD 90 million in valuation by 2027 with a surge in the consumption across pharmaceutical applications.